Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lenvatinib

EU orphan designation number: EU/3/13/1121   
Active ingredient: Lenvatinib
Indication: Treatment of papillary thyroid cancer
Sponsor: Eisai Europe Limited
European Knowledge Centre, Mosquito Way, Hatfield, Herts AL10 9SN, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2013 Centralised Orphan - Designation EMA/OD/173/12 (2013)2558 of 26/04/2013